United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Healthcare Industry News Inside Else Nutrition’s CFO shuffle: What Natie Zilberberg’s appointment means for capital strategy in 2026 Else Nutrition has appointed Natie Zilberberg as CFO amid U.S. retail expansion and cash flow challenges. Explore what this leadership move really signals. byPallavi MadhirajuJanuary 6, 2026